BLEVF — Beleave Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $8.84m
- CA$2.37m
Annual income statement for Beleave, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 2.37 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | -0.334 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.51 | 2.99 | 8.55 | 12.6 | 36.2 |
| Operating Profit | -0.51 | -2.99 | -8.55 | -12.6 | -33.8 |
| Net Income Before Taxes | -0.51 | -2.99 | -8.55 | -12.6 | -33.8 |
| Net Income After Taxes | -0.51 | -2.99 | -8.55 | -12.6 | -33.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.51 | -2.99 | -8.55 | -12.6 | -33.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.51 | -2.99 | -8.55 | -12.6 | -33.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.006 | -0.015 | -0.056 | -0.046 | -0.062 |
| Dividends per Share |